Pharmacovigilance is essential in evaluation of a new medicinal product’s safety and efficacy, before and after market placement. Through successful Clinical Trial Safety Monitoring and Post Marketing surveillance, potential risks that could harm users are defined and minimized. Each procedure, must be monitored by an experienced Pharmacovigilance vendor to ensure it follows proper assessment practice. It is crucial for the product to be proven safe once it has been made available to the public. Careful monitoring and evaluation of ADRs is the only way to establish a product as safe and effective for further public consumption.
With our organizational and technical support, we meet the individual needs of our worldwide clients. We offer a global, world-wide coverage of full pharmacovigilance services in both, clinical phase of the drug development and in post-market surveillance. Our services include LQPPV and EUQPPV services, reporting to regulatory authorities, preparing relevant safety documents and continuous monitoring of products’ safety profiles, all whilst staying compliant with the legislation of individual countries.
